PharmaZell Group is pleased to announce that the US Food and Drug Administration has granted approval of Breckenridge Pharmaceutical, Inc. Abbreviated New Drug Application for Teriflunomide 7mg & 14mg Tablets (generic for Aubagio®) on September 24, 2021. This product was developed by PharmaZell in collaboration with Breckenridge. The received FDA approval will allow Breckenridge, based
Moving forward in plan. Reactors and Centrifuges are in place…
We are pleased to announce that PharmaZell(India)Private Limited has been awarded EcoVadis Silver Medal in Recognition for Sustainability Performance. This Recognition places our company among the top 25 percent of companies assessed by EcoVadis.
New expansion of fully automated and dedicated Production facility for Mesalamine has picked up its momentum at Visakhapatnam site. It is targeted to start the production in October-2021. Impact of COVID-19 lead to few disturbances for 2-3 weeks, however there are adeuqate buffer time in plan to mitigate potential delays. Majority of the equipment are
20 April 2021, Gropello. Farmabios Spa, part of the PharmaZell Group, is pleased to announce it has received validation from the European Commission (“EC”), and European Food Safety Authority (“EFSA”) for the dossier on synthetic CBD as a Novel Food.
CEO Dr. Oliver Bolzern visited the Visakhapatnam site in February. He appreciated the various measures and efforts taken during COVID pandemic which has helped to restrict any potential disturbance in the operations.
The construction of the new steroid building is even in Covid-19 times running smoothly and almost on schedule. The department would have three layers for 980 m3 total with a state of art technology. We are looking forward use the additional capacities as planned.
FarmaBios successfully completed the certification process in accordance with the ISO 45001:2018 standards. The new certificate is the last achievement of the list together with ISO 9001:2015 and ISO 14001:2015. With this certificate valid until 28th July 2023, FarmaBios presents objective evidence for the commitment to provide high quality and to works on continuous improvement